Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
about
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptorsAntianginal actions of beta-adrenoceptor antagonistsIs It Time to Beta Block the Septic Patient?Prevention of skin carcinogenesis by the β-blocker carvedilolAssembly of a beta2-adrenergic receptor--GluR1 signalling complex for localized cAMP signallingPro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent.Discovery of regulators of receptor internalization with high-throughput flow cytometry.Network analysis of FDA approved drugs and their targets.Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.High-throughput de novo screening of receptor agonists with an automated single-cell analysis and isolation system.Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.Propranolol Reduces Cancer Risk: A Population-Based Cohort Study.Adrenergic modulation of olfactory bulb circuitry affects odor discrimination.Beta-adrenergic blocking drugs in breast cancer: a perspective reviewβ2-Adrenergic receptor supports prolonged theta tetanus-induced LTPBeta1-adrenergic receptor-mediated dilation of rat cerebral artery requires Shaker-type KV1 channels on PSD95 scaffoldSelective Inhibition of Bacterial Tryptophanyl-tRNA Synthetases by Indolmycin Is Mechanism-based.β-blockers: a novel class of antitumor agents.Bisoprolol in the treatment of chronic heart failure.The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cellsAlpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged accessThe 27-kDa heat shock protein confers cytoprotective effects through a beta 2-adrenergic receptor agonist-initiated complex with beta-arrestin.Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.Defying the economists: a decrease in heart rate improves not only cardiac but also endothelial function.Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.β-adrenergic signaling broadly contributes to LTP induction.Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus.Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists.Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.Novel selective β1-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.Inhibition of a TREK-like K+ channel current by noradrenaline requires both β1- and β2-adrenoceptors in rat atrial myocytes.The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
P2860
Q24670735-4538C9BE-8456-4CE0-B903-48980F500B7DQ24682302-21E12B27-015B-4296-967B-71D9D026E724Q26777818-37125DD9-33EC-4E54-9F3D-CC206DE6AA3BQ28385654-E25312E4-1B62-4207-AB32-4C34A8365FD3Q28581205-37F6B145-71F5-4CAB-9410-E477B0E24B74Q33823097-214B5385-D436-4B3B-8EC8-EA31EFB75432Q34327895-1C412D76-31E7-41DA-87D3-B5E351B7BF0EQ34630429-2484D39F-D4AF-451C-A75A-73D9C6078641Q34837191-D6833112-D737-4694-8E39-F41BB03712EFQ35104210-79FBB124-ABC5-45BE-9CF4-EEA1972A31DFQ35114450-B26A7FA2-0482-4FE9-8313-6BCE0D1CE801Q35557410-D1F4B960-4A3B-47F8-9433-7FB36AE2BA99Q35858235-C4DA7615-F516-46EC-B012-CEBB11E5448BQ35949176-E4E2E1BC-7168-407C-AA21-947CDBF66228Q35949297-2EF56529-2953-410B-97B3-5E864CD71858Q35994868-C66E38C9-147B-4A90-9E26-C9CA5777BA1DQ36267511-63CD1E9C-5F33-4241-9BA7-0AF83A923DECQ36419245-D185E4D9-0BB7-47AA-A2E7-F62CFD42DA6FQ36443830-6F3A37D1-BA1B-49E9-A674-23486E908778Q36536259-A3EDCFB6-DB9C-4973-A351-511B33627574Q36614361-00C1576B-7CA9-4B1C-8D51-9D5ABA26B3FBQ36645946-7D73DC72-FDC6-4A26-A4B4-3478EFD06718Q37199137-646A856C-10A4-4B9D-9B06-359D4B8E6279Q38951165-F7C31CF5-2B65-4713-9063-0446C344A8D7Q39573042-D481D342-1A7F-4E3A-A11C-80827B570132Q40346347-30C2FFC0-BB40-4579-8E2B-3CAFDF9CEF04Q41282699-3D8B3D8A-7270-42A8-B534-EAA8F4484B6FQ41295868-21B2C4C2-AFB9-4F20-99CC-24D3AEC8E599Q41571207-163CD57A-2485-4026-8E87-D60579D7A6C9Q42191909-38F20770-D844-4081-BAD1-42DE1501C1F4Q42201896-E8D62D31-C8A5-4304-A2C5-D68C3133BF9BQ42226298-3898DFC7-3F91-43FC-93A7-BF86981A722FQ42429572-3ADE418E-9332-40FB-A3AD-3080E98056B3
P2860
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@ast
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@en
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@nl
type
label
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@ast
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@en
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@nl
prefLabel
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@ast
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@en
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@nl
P1476
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
@en
P2093
P407
P577
1999-04-01T00:00:00Z